chrisvoncsefalvay/vaers-outcomes huggingface dataset:
light headedness; feelings of almost fainting; tingling in my right arm; pounding heart / sometimes my heart felt like it was in my throat that was taking my breath away; occasional chest pain; sometimes my heart felt like it was in my throat that was taking my breath away; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (005570). The reporter is the patient.  A 31-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Lot number: FA9091) for covid-19 immunisation. The patient's relevant medical history included: "Schizoaffective disorder" (unspecified if ongoing). Concomitant medication(s) included: TETANUS VACCIN taken for immunisation, in Aug2022 as dose number unknown, single; OLANZAPINE taken for schizoaffective disorder. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "light headedness"; PRESYNCOPE (non-serious), outcome "unknown", described as "feelings of almost fainting"; PARAESTHESIA (non-serious), outcome "unknown", described as "tingling in my right arm"; PALPITATIONS (non-serious), outcome "unknown", described as "pounding heart / sometimes my heart felt like it was in my throat that was taking my breath away"; CHEST PAIN (non-serious), outcome "unknown", described as "occasional chest pain"; DYSPNOEA (non-serious), outcome "unknown", described as "sometimes my heart felt like it was in my throat that was taking my breath away". The events "light headedness", "feelings of almost fainting", "tingling in my right arm", "pounding heart / sometimes my heart felt like it was in my throat that was taking my breath away", "occasional chest pain" and "sometimes my heart felt like it was in my throat that was taking my breath away" required emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The reporter assessed the events as non-serious. The patient was wondering if it was safe for me to get the COMIRNATY bivariant COVID-19 vaccine given my past experience of heart symptoms. The patient went to the Emergency room but there was no specified treatment. Within in 4 weeks of suspect vaccination the patient received tetanus shot and patient wanted to know if he has to wait before get the COVID bivalent vaccine.  Follow-Up (14Oct2022): Follow-up attempts are completed. No further information is expected.
Temp 100.7. Generalized tonic/clonic seizure 2 times each less than 5 minutes. No treatment given. The hospital discharge summary received on 2/19/04 states fever, vomiting, increased crying, and decreased appetite. oN 2/19/2004, pt developed a fever followed by seizure. Pt started on phenobarbital and was evaluated by a neurologist. No hospitalization or ER visit required. MD wanted to update as he believes fever was trigger for seizure. After previously reported AE-not the vaccines directly.
Information has been received from a health professional concerning a 4 year old male who on 12-JUN-2007 with no medical history or allergies was vaccinated on left leg with a dose of varicella virus vaccine live (Oka/Merck) (Lot # 657456/0600U). Concomitant therapy included a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (MSD) on left leg. Other concomitant therapy on right leg included a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid, a dose of hepatitis A virus vaccine (unspecified), a dose of hepatitis B virus vaccine (unspecified) and "fluoride". On 13-JUN-2007 it was reported that patient developed cellulitis after receiving several vaccines. The affected area was large and around the injection site the skin was sore, warm to touch and red. The patient was started on Augmentin on 14-JUN-2007. He was then changed to clindamycin on 15-JUN-2007 when the area did not improve. The cellulitis had resolved. On 23-JUN-2007, the patient developed a fever. On 24-JUN-2007, the patient developed a papulovesicular rash on the back of his neck, legs and chest. At the time of report the patient had not recovered. A product quality complaint was not involved. Further information has been received from the physician regarding this male with four siblings who was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck). Concomitant therapy included the first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Lot # ) IM on left leg, a dose of diphtheria toxoid (+) pertussis vaccine unspecified (+) tetanus toxoid GSK (lot # AU21b115bb) IM third dose and a first dose of hepatitis A virus vaccine (unspecified) GSK) (LOT # AHAVB14BAA) and "fluoride". The physician reported that on 12-JUN-2007 the patient's injection site was red swollen and warm. The physician reported that the possible cellulitis was treated with Augmentin then clindamycin. The physician reported that the patient improved. The physician reported that there was questionable MRSA at the site. Additional information is not expected.
Client was given Flumist. On 10/31/2013, she then was at her Doctors for a check up and he told her to never get Flumist again. After she got the Flumist, she had to use her inhaler bid for one week.  When asked if she had any problems with the first Flumist, client stated no. She recieved Flumist once before on 11/17/2011, she also said she went to ER after that time and had trouble breathing due to asthma.
The initial spontaneous case, received on 12-Oct-2017 reported by other health professional (nurse), concerning a 37-year-old, adult, male patient. On an unspecified date, the patient was administered with influenza virus vaccine polyvalent, dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported. On the same day after vaccination at night, the patient experienced extensive bruising which seemed to be blue and black colored whole upper arm where vaccine was administered. The patient stated that, bruise had not caused any hurt and there were no other systemic reactions were reported by the patient. The outcome of the event was not reported. The reporter assessed this case as non-serious. Significant case correction received 12-OCT-2017: Event 'reaction to drug excipient' was added. Reporter Causality was changed from not reported to related.
Dizziness. Dizziness increase as head is turned side to side; Vertigo; The patient received third/booster dose of BNT162b2; The patient received Moderna dose 1 on 23Mar2021, dose 2 on 20Apr2021 and received booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FJ1611) via an unspecified route of administration in the left arm on 08Nov2021 at 17:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and low blood pressure. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of COVID-19 vaccine mRNA (mRNA 1273) (MODERNA COVID-19 VACCINE; Lot Number: 04J21A) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 31-years-old) and second dose of COVID-19 vaccine mRNA (mRNA 1273)(MODERNA COVID-19 VACCINE; Lot Number: 044B21A) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 31-years-old); both as single doses for COVID-19 immunisation. On 09Nov2021 at 15:00, the patient experienced dizziness and vertigo. Dizziness increased as head turned side to side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness and vertigo; dizziness increased as head turned side to side was unknown at the time of this report.
Moderna COVID?19 Vaccine  First noticed below symptoms on April 9th, approximately 48 hours after 1st dose of vaccine. Lasted about 9 days, went away for a week and then came back and was a bit worse: Tingling in both feet and legs, gradually over time going higher in legs, not in feet anymore. Some pain in legs...not sharp pains, but dull pains on and off in various places in legs throughout day. Doesn't interfere with sleep or daily activities but is constantly there. Feel a bit stiff when I get up. As day goes on, seems to be more noticeable. Has gone to hip and lower back area once, sometimes noticeable in arms. But the only constant area is the legs below and above knees. Have never had this issue before. Recently had check up and bloodwork before vaccine and no health issues.
This spontaneous report as received from a healthcare worker referring to a patients of unknown age and gender. Since 02-NOV-2015, the patients were vaccinated with PROQUAD (Merck) (dose, frequency and route of administration were not reported, lot# L030589 expiration date: 01-FEB-2017; lot# L019997 expiration date: 02-DEC-2016), which were exposed to temperatures outside of the recommended range. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
On April 12 2021, I suddenly heard a loud noise in my head and then experienced a very loud tone sound in my head, then loud tinnitus in both ears.  In the right ear, on and off for a few days.  In the left ear, I am left with much louder constant tinnitus.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: ems was called to have patient checked, pt is okay and went home with mom. Patient felt lightheaded and felt like she was going to faint.
pt recvd vax & exp achiness, fever, chills, 8 days p/vax exp jaundice; pt's s/sx disappeared 13DEC94 & was able to return to work;
One and a half hours post vax the pt experienced a screaming reaction. The pt remained afebrile. Subsequently the pt recovered the following day. Similar experienced were reported. (WAES99120429, 99120443, 99120438). Unspecified medical attention was sought. No further information is available.
Severe sepsis without septic shock. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
CDC reports: 2 yo child rec'd DTP/OPV on 28FEB90. On 1MAR90 developed a rash.
Information has been received from a healthcare worker concerning three unspecified patients of unknown gender and age. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 11-APR-2016, these patients were vaccinated with doses of improperly stored (Merck) VARIVAX (strength, dose and route not reported, lot # L043619 with expiration date 02-NOV-2017 and lot # 48467 with expiration date 02-DEC-2017). The vaccines were exposed to 11 degree Celsius for 48 hours. There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
Body aches; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 08Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 administered on an unspecified date for COVID-19 immunization. On an unspecified date the patient experienced body aches. It was reported by the patient that "patient and patient's husband had their second vaccine on Monday, last Monday, a week ago, 8Feb2021 (later confirmed). And they neither had any problems with the first one. And with the second one, the patient had few body aches." The clinical outcome of the event was unknown.   Follow-up attempts completed. No further information expected.
L parietal infarct with hemorrhage and occlusive thrombus in L transverse and sigmoid sinuses. started on heparin infusion. Currently being treated in our surgical intensive care unit.
Administrated the incorrect flu vaccine on 10/3/23. This individual received the high dose Fluad meant for individuals 65 and older instead of the Flucelvax 6 months and older flu vaccine accidently. Patient has been notified. Administrator has been notified and re-educated on proper administration and has reported the error. No adverse reactions, signs or symptoms from the recipient reported.
Shoulder impingement, inflammation, stiffness.. also neck stiffness  and pulsating headaches on right side of head (same side as shoulder that  Vaccine took place . Had a dizzy spell in 10/2021, which led to an ER visit. Was given meds to lessen the dizziness and prevent vomiting.
Injection site redness and rash, treated on 5/2/13 with Zyrtec and ultravate.  Patient to start falters only if blistering occurs.
14 hours after the vaccine: extreme cold with shaking even under many layers, restlessness and joint/bone pain throughout entire body 20 hours after: shaking resolved but joint/bone pain worsened and headache is somewhat debilitating. Took 600mg ibuprofen and 975mg Tylenol with 25% relief 26 hours after: improved only a headache remains
Pt developed fever, prolonged crying and brief (about 2 minutes) of generalized seizure.
flu; Initial information received on 17-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from patient.  This case involves an unknown age and unknown gender patient who had flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (form, strength, dose, frequency, lot number, expiry date: unknown) via unknown route in unknown administration site for flu vaccination.  On an unknown date the patient developed flu (influenza) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.   Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event ( flu).  At time of reporting, the outcome was Unknown for the event flu.
3 day hx of Rt arm pain;began 8-10 hrs /p admin of Td. No rashes,but 2cm lesion over inject site.
Hours later: Swelling at the injection site and covid-like symptoms for 2 weeks. Several months unable to use arm as normal. It seemed to subside after 6 months and then flared up again 2 months later. Unable to extend arm at times. Tingling at times: in the arm at injection site and sometimes down left back shoulder blade.
4 days after the vaccine I developed UTI symptoms that became increasingly painful.; Flushing of face and chest 30 minutes after receiving the vaccine.; This is a spontaneous report from a contactable consumer (patient).   A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 23Apr2021 14:30 (Batch/Lot Number: EW0161) at the age of 28-year-old as SINGLE DOSE for covid-19 immunisation. The COVID-19 vaccine was administered at Hospital. Medical history included allergies to Sulfa, amoxicillin sodium;clavulanate potassium (AUGMENTIN). Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The patient's concomitant medication included Birth Control. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. The patient experienced Flushing of face and chest 30 minutes after receiving the vaccine on 23Apr2021 15:00. 4 days after the vaccine on 28Apr2021, the patient developed Urinary tract infection (UTI) symptoms that became increasingly painful. After teledoc visit patient started an antibiotic (macrobid) and the symptoms continued to worsen. Patient saw her Obstetrics and gynaecology (OBGYN) office and was given Ciprofoxacin and a culture test. The culture came back negative for infection. The pain became severe 7 days after the initial pain and were severe until 11 days after the initial symptoms. After about 13 days it was tolerable, but still uncomfortable. There were burning, pulling, pinching and pressure sensations during this time and it was incredibly painful to urinate, adverse event resulted in: Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering.
headache, Myalgia, Fever & NauseaVomiting Narrative:
I received the 2nd covid vaccine on thursday evening at 6:40pm. On the following Saturday I developed a red raised rash on the right side of my body, mostly arm and neck. I took 25mg benadryl. Rash lasted about 6h.
Unconscious; Hearing loss; leg paralyzed. 12/15/08-records received for DOS 10/21-10/26/08-DC DX:Adrenal insufficiencey. Infections, complications, affecting treatment/stay. Migraines. Admitted with hypotensive status and respiratory rate of 3. Echo 55%, hypotension and heart failure improved. Most likely cause of hypotension was benzo or opioid overdose or central adrenal insufficience possibly 2/2 opioids or less likely steroid use during nasal septum surgery. Developed LE weakness question of muscle swelling vs other polyneuropathy.  Gradual improvement in ability to weight bear. Right sided hearing loss acutely unclear cause now improving. Follow-up: See attached letter, found daughter unconscious loss use of hearing and legs 10/20/08 7:30AM brought to hospital ICU. I am the mother of patient whose letter is dated November 23, 2008. I also had the same flu shot Influenza Brand Name: FLUARIX, Manufacturer, Glaxo-Smith Kline, AFLUA375AA Exp. 6/30/09. Since this shot I also have had pain on the top of my foot - nothing of the magnitude of patient's problem, but I thought it important to let you know. We are hoping for a response to this problem. Please find enclosed information you requested Influenza Brand Name: FLUARIX, Manufacturer, Glaxo-Smith Kline. AFLUA375AA Exp. 6/30/09. This vaccine was given to my daughter on 10/14/08 and on 10/20/08 the following occurred: she was found by me unconscious and unresponsive. She lost the use of her legs and hearing. She was at hospital ICU for 1 day and transferred until 10/26/08. During her stay at the hospital, she encountered migraine headaches the entire time. The doctors she saw were general, endocrinologist, neurologists, and orthopedic surgeon. They have not come to a definite conclusion as to why she passed out originally and hit her head and why was her entire body was effected such as blood pressure, sugar, liver, heart, etc. I feel there is a possibility the shot could of caused this problem. She has regained her hearing but her right leg and foot has severe nerve damage and is very very painful. She has physical distress and is unable to do anything. She cannot drive, walk well, eat, go to work, and ride her horse (no activities). She remains in bed all day except to go out for physical therapy. She has now lost her job, which took her a year to find after getting out of college. Her wages biweekly were $1077.00. She now she has to pay Cobra at the cost of $645.00 per month. This is a financial burden to me because my husband has Parkinson's disease for over 28 years and is in a day care during the day...she was helping me take of him and now she can no longer do so. I would appreciate a response to this situation as soon as possible.
body aches- 2 days, fever-2 day2, sweats- 2days, left arm tremors and brain tremors- 1-2 weeks off and on,  arm pain and rash- 1 week, fatigue- 2 weeks, diarrhea- 3 weeks, nausea- 3 weeks, muscle weakness - 5 weeks, debilitating headaches-5 days, headaches - 5 weeks, dizziness and brain fog- 6 weeks,  chest pain and heart palpitations- 6 weeks
Sweating, headache, nausea, light headedness, blacked out, dizzy, body aches - after second dose.  Tried Ibuprofen so far.  Waiting to see if there is relief.  Can barely stand on his own.
VOLUNTEER FOR DISASTER RELIEF.  C/O RASH ON ARMS, DIZZINESS, AND ITCHING. TRANSPORTED BY AMBULANCE TO EMERGENCY ROOM.  SYMPTOMS RESOLVED BY THE TIME OF HIS ARRIVAL AT ER.  CHART DX:  ALLERGIC REACTION.  B/0 162/80; PULSE 88; RESP 20; OXYGEN SAT 98%.
severe hair loss; skin disorder; itching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "severe hair loss"; SKIN DISORDER (non-serious), outcome "unknown", described as "skin disorder"; PRURITUS (non-serious), outcome "unknown", described as "itching".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
lowering immune system; Side effects; This case was reported by a consumer and described the occurrence of immune system disorder in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced immune system disorder and adverse drug reaction. On an unknown date, the outcome of the immune system disorder and adverse drug reaction were unknown.   It was unknown if the reporter considered the immune system disorder and adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The patient was concerned with the side effects (which he had with the first shot) possibly lowering his immune system in such a way that if he contacted the coronavirus, it could be more harmful to him. The reporter wanted to know was it ok to get the second shot at a later date.
Decreased visual acuity per patient that started approximately 45 minutes post injection. Patient seen by the doctor and discharged home.
Swelling on injected arm, swelling in eyes, fatigue, large welt at injection site, pain in injected arm
I started experiencing shortness of breath after coming up a flight of stairs, bending over to reach an item, and even walking from the parking lot of my job into the building. I visited a cardiologist, and they conducted a chemical stress test to see if I was suffering from atrial fibrillation that my smart watch has been picking up since then. I have a follow-up appointment with the same cardiologist on 01/30/2023 for another examination to see what's causing my heart problems.
Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Mild, Systemic: Weakness-Mild, Additional Details: pt gets nervous during shots
Patient received an injection of MENACTRA in her (R) deltoid on 7-16-10 here at clinic.  Patient went to hosp. ER on 7-17-10 with complaint of pain, redness, and edema at injection site.  Patient given scripts for CEPHALEXIN 500 mg one tab bid for 10 days and TRIMETHOPRIM/SULFAMETHOXAZOLE 160/800 mg one tab bid for 10 days for dx of cellulitis.  Patient then discharged home.